Novel tamoxifen derivative Ridaifen-B induces Bcl-2 independent autophagy without estrogen receptor involvement

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 657-663

  Nagahara, Yukitoshi ^a   Takeyoshi, Midori ^a   Sakemoto, Seiya ^a   Shiina, Isamu ^b   Nakata, Kenya ^b   Fujimori, Keiko ^b   Wang, Yanwen ^b   Umeda, Eri ^b   Watanabe, Chihiro ^b   Uetake, Shoko ^b   Yamori, Takao ^c   Dan, Shingo ^c   Yoshimi, Yoji ^b   Shinomiya, Takahisa ^b   Ikekita, Masahiko ^b  

^a TOKYO DENKI UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Autophagy; Bcl 2; Beclin 1; LC3; Ridaifen B

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN BCL 2; RIDAIFEN B; TAMOXIFEN DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOLYSOSOME; AUTOPHAGY; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYSOSOME; MITOCHONDRION; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, HORMONAL; AUTOPHAGY; HUMANS; JURKAT CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRROLIDINES; RECEPTORS, ESTROGEN; TAMOXIFEN;

EUKARYOTA;

EID: 84878988772     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.040     Document Type: Article

References (28)

1. Mizushima N. Autophagy: process and function. Genes Dev. 2007, 21:2861-2873.
2. Shintani T., Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 2004, 306:990-995.
3. Cuervo A.M. Autophagy: in sickness and in health. Trends Cell Biol. 2004, 14:70-77.
4. Mijaljica D., Prescott M., Klionsky D.J., Devenish R.J. Autophagy and vacuole homeostasis: a case for self-degradation?. Autophagy 2007, 3:417-421.
5. Funderburk S.F., Wang Q.J., Yue Z. The Beclin 1-VPS34 complex-at the crossroads of autophagy and beyond. Trends Cell Biol. 2010, 20:355-362.
6. Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H., Overvatn A., Bjorkoy G., Johansen T. P62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 2007, 282:24131-24145.
7. Pattingre S., Espert L., Biard-Piechaczyk M., Codogno P. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 2008, 90:313-323.
8. Yorimitsu T., Klionsky D.J. Eating the endoplasmic reticulum: quality control by autophagy. Trends Cell Biol. 2007, 17:279-285.
9. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., Packer M., Schneider M.D., Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
10. Oh S., Xiaofei E., Ni D., Pirooz S.D., Lee J.Y., Lee D., Zhao Z., Lee S., Lee H., Ku B., Kowalik T., Martin S.E., Oh B.H., Jung J.U., Liang C. Downregulation of autophagy by Bcl-2 promotes MCF7 breast cancer cell growth independent of its inhibition of apoptosis. Cell Death Differ. 2011, 18:452-464.
11. Kimmelman A.C. The dynamic nature of autophagy in cancer. Genes Dev. 2011, 25:1999-2010.
12. Notte A., Leclere L., Michiels C. Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem. Pharmacol. 2011, 82:427-434.
13. Xi G., Hu X., Wu B., Jiang H., Young C.Y., Pang Y., Yuan H. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett. 2011, 307:141-148.
14. Jo Y.K., Park S.J., Shin J.H., Kim Y., Hwang J.J., Cho D.H., Kim J.C. ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells. Biochem. Biophys. Res. Commun. 2011, 404:1039-1043.
15. de Medina P., Silvente-Poirot S., Poirot M. Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation. Autophagy 2009, 5:1066-1067.
16. Cho K.S., Yoon Y.H., Choi J.A., Lee S.J., Koh J.Y. Induction of autophagy and cell death by tamoxifen in cultured retinal pigment epithelial and photoreceptor cells. Invest. Ophthalmol. Vis. Sci. 2012, 53:5344-5353.
17. Nagahara Y., Shiina I., Nakata K., Sasaki A., Miyamoto T., Ikekita M. Induction of mitochondria-involved apoptosis in estrogen receptor-negative cells by a novel tamoxifen derivative, ridaifen-B. Cancer Sci. 2008, 99:608-614.
18. Shiina I., Sano Y., Nakata K., Suzuki M., Yokoyama T., Sasaki A., Orikasa T., Miyamoto T., Ikekita M., Nagahara Y., Hasome Y. An expeditious synthesis of tamoxifen, a representative SERM (selective estrogen receptor modulator), via the three-component coupling reaction among aromatic aldehyde, cinnamyltrimethylsilane, and beta-chlorophenetole. Bioorg. Med. Chem. 2007, 15:7599-7617.
19. Shiina I., Sano Y., Nakata K., Kikuchi T., Sasaki A., Ikekita M., Nagahara Y., Hasome Y., Yamori T., Yamazaki K. Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents. Biochem. Pharmacol. 2008, 75:1014-1026.
20. Polson H.E., de Lartigue J., Rigden D.J., Reedijk M., Urbe S., Clague M.J., Tooze S.A. Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. Autophagy 2010, (6).
21. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19:5720-5728.
22. Schoenlein P.V., Periyasamy-Thandavan S., Samaddar J.S., Jackson W.H., Barrett J.T. Autophagy facilitates the progression of ERalpha-positive breast cancer cells to antiestrogen resistance. Autophagy 2009, 5:400-403.
23. Poirot M., Silvente-Poirot S., Weichselbaum R.R. Cholesterol metabolism and resistance to tamoxifen. Curr. Opin. Pharmacol. 2012, 12:683-689.
24. Ishibashi S., Yamazaki T., Okamoto K. Association of autophagy with cholesterol-accumulated compartments in Niemann-Pick disease type C cells. J. Clin. Neurosci. 2009, 16:954-959.
25. Carloni S., Girelli S., Scopa C., Buonocore G., Longini M., Balduini W. Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia. Autophagy 2010, 6:366-377.
26. Juenemann K., Reits E.A. Alternative macroautophagic pathways. Int. J. Cell. Biol. 2012, 2012:189794.
27. Scarlatti F., Maffei R., Beau I., Codogno P., Ghidoni R. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ. 2008, 15:1318-1329.
28. Smith D.M., Patel S., Raffoul F., Haller E., Mills G.B., Nanjundan M. Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells. Cell Death Differ. 2010, 17:1867-1881.